Edwards Lifesciences Corporation (EW)
NYSE
Closed
Oct 7, 2026
Day's Range
85.4952 wk Range
72.30Overview - EW - Edwards Lifesciences Corporation
Key Statistics
Valuation
Enterprise Value
45.63B
P/E (Trailing)
‪50.68‬
P/E (Forward)
‪25.21‬
PEG Ratio
‪-1.92‬
Price / Sales (TTM)
‪7.52‬
Price / Book
‪4.62‬
EV / EBITDA
‪22.85‬
Profitability
Gross Margin
‪77.46%‬
Profit Margin
‪15.43%‬
Operating Margin
‪29.83%‬
Return on Assets
‪8.36%‬
Return on Equity
‪9.17%‬
Ownership
Shares Outstanding
576.60M
Float
574.49M
Short % of Shares Outstanding
‪1.79%‬
Held by Insiders
‪0.19%‬
Held by Institutions
‪95.61%‬
Price stats
Beta
‪0.85‬
50-Day Avg
‪88.48‬
200-Day Avg
‪85.13‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
29 analysts
Average price target
‪$ 100.96‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - EW - Edwards Lifesciences Corporation
Peers - EW - Edwards Lifesciences Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
- EWNYSEEdwards Lifesciences Corporation49.08BMarket Cap+10.09%52-week change50.68P/E (Trailing)‪15.43%‬Profit Margin
- CVXNYSEChevron Corporation406.24BMarket Cap+25.86%52-week change19.95P/E (Trailing)‪9.83%‬Profit Margin
- ABTNYSEAbbott Laboratories169.82BMarket Cap-37.17%52-week change31.55P/E (Trailing)‪11.64%‬Profit Margin
- MDTNYSEMedtronic plc110.49BMarket Cap-13.95%52-week change21.28P/E (Trailing)‪13.93%‬Profit Margin
- SYKNYSEStryker Corp.105.64BMarket Cap-32.98%52-week change28.32P/E (Trailing)‪14.43%‬Profit Margin
- ICENYSEIntercontinental Exchange, Inc.84.29BMarket Cap-5.93%52-week change21.39P/E (Trailing)‪38.24%‬Profit Margin
- BSXNYSEBoston Scientific Corp.61.73BMarket Cap-127.00%52-week change17.25P/E (Trailing)‪17.49%‬Profit Margin
Profile Summary - EW - Edwards Lifesciences Corporation
About
Edwards Lifesciences Corporation is a medical technology company focused on structural heart disease and critical care monitoring. Edwards Lifesciences develops and markets transcatheter aortic valve replacement systems, transcatheter mitral and tricuspid therapies, and surgical structural heart products used to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
